Perbandingan Efektivitas Terapi Injeksi Intralesi 5- Fluorourasil dengan Triamsinolon Asetonida terhadap Perbaikan Klinis Keloid
DAFTAR PUSTAKA
1. Burrows NP, Lovell CR. Disorders of connective tissue. In : Burns T, Breathnach
S, Cox N, editors. Rook’s Textbook of Dermatology. 8thedition. Wiley-Blackwell,
Ltd. 2010.p.45.54-6
2. Khan SA. Keloid an update. Physician Academy [internet] 2008, 2(6): 25-9.
Available from: http://www.physicians-academy.com/Upload/753676f2-e6b74b94-b36f-7b88236d1ef9.pdf
3. Seifert O, Mrowietz U. Keloid scarring : bench and bedside. Arch Dermatol Res
2009; 301: 259-72. DOI: 10.1007/s00403-009-0952-8
4. Robles DT, Moore E, Draznin M. Keloids: Pathophysiology and management.
Dermatology Online Journal [internet] 2007; 13(3): 9-13. Available from:
http://escholarship.org/uc/item/2m43548
5. Urioste SS, Arndt KA, Dover JS. Keloid and hypertrophic scars: Review and
treatment strategies. Seminars in Cutaneous Medicine and Surgery [internet]
1999; 18(2): 159-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/
10385284
6. Robles DT, Berg D. Abnormal wound healing: keloids. Clinics in Dermatology
[internet] 2007; 25: 26-32. DOI:10.1016/j.clindermatol.2006.09.009
7. Putra IB, Jusuf NK. Studi Retrospektif Keloid di Poliklinik Kulit dan Kelamin
RSUP H. Adam Malik Medan. 12th Asia-Pasific Environmental and Occupational
Dermatology Symposium; 2013 Oct 23-26; Yogyakarta: Indonesia
8. Juckett G, Adams HH. Management of keloids and hypertrophic scars. Am Fam
Physician
2009;
80(3):
253-260.
Available
from:
http://www.aafp.org/afp/20090801/253-s1.html.
9. Kranendonk S, Obagi S. An algorithmic approach to hypertrophic scars and
keloids: Maximizing nonsurgical options. Cosmetic Dermatology [internet]
2011; 24(1). Available from: http://www.cosderm.com/fileadmin/qhi_archive/
ArticlePDF/CD/024010028.pdf
10. Wolfram D, Tzankov A, Pulzi P. Hypertrophic scars and keloids – A review of
their pathophysiology, risk factors, and therapeutic management. Dermatol Surg
2009; 35: 171-81. DOI: 10.1111/j.1524-4725.2008.34406.x
11. Prabhu A, Sreekar H, Powar R, Uppin VM. A randomized controlled trial
comparing the efficacy of intralesional 5-fluorouracil versus triamcinolone
acetonide in the treatment of keloid. Journal of the scientific society 2012; 39(1):
19-25. DOI: 10.4103/0974-5009.96466
74
75
12. Darougheh A, Asilian A, Shariati F. Intralesional triamcinolone alone or in
combination with 5-flurouracil for the treatment of keloid and hypertrophic scars.
Clinical and Experimental Dermatology 2007; 34: 219-23. DOI:10.1111/j.13652230.2007.02631.x
13. Hatamipur E, Mehrabi S, Hatamipoor M. Effects of combined intralesional 5flurouracil and topical silicone in prevention of keloid: A double blind
randomized clinical trial study. Acta Medica Iranica [internet] 2011; 49(3): 12730. Available from: http://acta.tums.ac.ir/files/journals/1/articles/4307/public/
4307-4664-1-PB.pdf
14. Perdanakusuma D. Parut abnormal. Dalam : Perdanakusuma D, Noer MS, editor.
Penanganan parut hipertropik dan keloid. Airlangga University Press. 2006 : 1326
15. Gautglitz GG, Korting HC, Pavicic T, et al. Hypertropic scarring and keloids :
Pathomechanisms and current and emerging treatment strategies. Mol Med 2011;
17(1) : 113 – 25. DOI: 10.2119/molmed.2009.00153
16. Butler PD, Longaker MT, Yang GP. Current progress in Keloid Research and
Treatment.
J. Am Coll of Surg 2008; 206(4), 731 – 40.
DOI:10.1016/j.jamcollsurg.2007.12.001
17. Alaish SM, Yager DR. Hyaluronic acid metabolism in keloid fibroblast. Journal
of Pediatric Surgery [internet] 1995; 30(7): 949-52. Available from:
http://www.jpedsurg.org/article/0022-3468%2895%2990319-4/pdf
18. Lee SS, Yosipovitch G, Chan YH, et al. Pruritus, pain, and small nerve fiber
function in keloids: a controlled study. J Am Acad Dermatol. 2004;51:1002-6.
DOI:10.1016/j.jaad.2004.07.054
19. Miteva M, Romanelli P. Hypertrophic and keloidal scars. In: Tosti A, Padova
MP, Beer KR, editors. Acne scars classification and treatment. Informa
Healthcare: 11-7
20. Hochman B, Localli RF. Intralesional triamcinolone acetonide for keloid
treatment: A systemic review . Aesth plast Surg 2008; 32: 705-9. DOI
10.1007/s00266-008-9152-8
21. Ogawa R. The most current algorithms for the treatment and prevention of
hypertrophic scars and keloids. Plast Reconstr Surg [internet] 2012; 125: 557-567.
DOI: 10.1097/PRS.0b013e3181c82dd5
22. Cho SB, Lee JH, Lee SH. Efficacy and safety of 1064 nm Qswitch Nd:YAG laser
with low fluence for keloids and hypertrophic scars. Journal European Academy
of Dermatology and Venerreology. 2010;24 : 1070-4. DOI: 10.1111/j.14683083.2010.03593.x
23. Shridharani MS, Magarakis M. Emerging role of antineoplastic agents in the
treatment of keloids and hypertrophic scars. Annals of Plast Surg 2010: 64: 35561. DOI: 10.1097/SAP.0b013e3181afaab0.
76
24. Gauglitz GG. Management of keloids and hypertrophic scars: current and
emerging options. Clinical, Cosmetic and Investigational Dermatology [internet]
2013; 6 : 103–14. Available from: http://dx.doi.org/10.2147/CCID.S35252
25. Berman B, Villa AM, Ramirez CC. Novel opportunities in the treatment and
prevention of scarring. J Cutan Med Sur [internet] 2005: 32-6. Available from:
http://link.springer.com/content/pdf/10.1007/s10227-004-0806-0.pdf
26. Qiao WX, Kai LY, Chun Q, et al. A Review of the Effectiveness of Antimitotic
Drug Injections for Hypertrophic Scars and Keloids. Ann Plast Surg 2009; 63:
688–92. DOI: 10.1097/SAP.0b013e3181978753
27. Putra IB. Pengaruh ekstrak kelopak bunga rosella (Hibiscus sabdariffa l) terhadap
penghambatan proliferasi sel fibroblast keloid manusia. Disertasi. Medan :
Program Doktor S3 Ilmu Kedokteran Fakultas Kedokteran Universitas Sumatra
Utara; 2012
28. Kelly AP. Update on the management of keloids. Semin Cutan Med Surg 2009;
28 : 71-6. DOI:10.1016/j.sder.2009.04.002
29. Nanda S, Reddy BS. Intralesional 5-Fluorouracil as a treatment modality of
keloids. Dermatol Surg [internet]
2004; 30(1): 54-6. Available from:
http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4725.2004.29382.x/pdf
30. Qiao WX, Kai LY, Yong WZ. Antimitotic drug injections and radiotherapy : A
review of the effectiveness of the treatment for hypertrophic scars and keloid.
International Journal of Lower Extremity Wound 2008; 7(3): 151-9. DOI:
10.1177/1534734608322099
31. Haurani MJ, Foreman K, Yang JJ. 5-flourouracil treatment of problematic scars.
Plastic Reconstr Surg 2009; 123: 139-47. DOI: 10.1097/PRS.0b013e3181904d1b
32. Sadeghinia A, Sadeghinia S. Comparison of the efficacy of intralesional
triamcinolon and 5-flurouracil tattooing for the treatment of keloids. Dermatol
Surg 2012; 38: 104-9. DOI: 10.1111/j.1524-4725.2011.02137.x
33. Sharma S, Bassi R, Gupta A. Treatment of small keloids with intralesional 5fluorouracil alone vs intralesional triamcinolone with 5-fluorouracil. Journal of
Pakistan Association of Dermatologist [internet] 2012; 22: 35-40. Available
from: http://www.jpad.org.pk/January-March2012/7.Original_article_Treatment_
keloids_5-FU_vs_5-FU_plus_triamcinolone_proofread.pdf
34. Gupta S, Kalra A. Efficacy and safety of intralesional 5-Fluorouracil in the
treatment of keloids. Dermatology [internet] 2002; 204(2): 130-32. Available
from: http://karger.com/journals/drm
35. Huang L, Wong YP, Cai YJ, et al. Low dose 5-fluorouracil induces cell cycle G2
arrest and apoptosis in keloid fibroblasts. British Association of Dermatologists
2010 ;163 : 1181–5. DOI 10.1111/j.1365-2133.2010.09939.x
77
36. Kontochristopoulus G, Stefanaki C, Panagiotopoulos A, et all. Intralesional 5Fluorouracil in the treatment of keloids: an open clinical trial and histopathologic
study. J Am Acad Dermatol. 2005; 52(3): 474-9. DOI:10.1016/j.jaad.2004.09.018
37. Pratchyapruit W, Vashrangsi N. A new therapeutic modality intralesional 5flourouracil in the treatment of keloids and hypertrophic scar. Institute of
Dermatology 2010; (10)2: 157-63. DOI 10.1007/s00266-006-0253-y
38. Werth VP. Systemic glucocorticoids. In: Wolff K, Goldsmith LA, Katz SI,
Gilrechrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in
general medicine. 7th edition. New York: Mc Graw-Hill.2008.p.2147-52
39. Bayat A, Arscott G, Ollier WER, Grouther DA, Ferguson MWJ. Keloid disease:
clinical relevance of single versus multiple site scars. The British Association of
Plastic Surgeons 2005; 58: 28-37. DOI:10.1016/j.bjps.2004.04.024
40. Naeni FF, Najafian J, Ahmadpour K. Bleomycin tattooing as a promising
therapeutic modality in large keloids and hypertrophic scars. Dermatol Surg
[internet] 2006; 32: 1023-30. Available from: http://onlinelibrary.wiley.com/
doi/10.1111/j.1524-4725.2006.32225.x/pdf.
41. Perdanasari AT, Lazzeri D, Su W, Xi W, Zheng Z, Ke Li, et al. Recent
developments in the use of intralesional injections keloid treatment. Arch Plast
Surg
[internet]
2014;
41:
620-9.
Available
from:
http://dx.doi.org/10.5999/aps.2014.41.6.620
42. Kelly AP. Medical and surgical therapies for keloids. Dermatologic Therapy.
2004,17: 212–8. DOI:10.1016/J.Sder.2009.04.002
43. Saha. AK. A comparative clinical study on role of 5-flurouracil versus
triamcinolone in the treatment of keloids. Indian J Surg. 2012: 1-4. DOI
10.1007/s12262-011-0399-y
1. Burrows NP, Lovell CR. Disorders of connective tissue. In : Burns T, Breathnach
S, Cox N, editors. Rook’s Textbook of Dermatology. 8thedition. Wiley-Blackwell,
Ltd. 2010.p.45.54-6
2. Khan SA. Keloid an update. Physician Academy [internet] 2008, 2(6): 25-9.
Available from: http://www.physicians-academy.com/Upload/753676f2-e6b74b94-b36f-7b88236d1ef9.pdf
3. Seifert O, Mrowietz U. Keloid scarring : bench and bedside. Arch Dermatol Res
2009; 301: 259-72. DOI: 10.1007/s00403-009-0952-8
4. Robles DT, Moore E, Draznin M. Keloids: Pathophysiology and management.
Dermatology Online Journal [internet] 2007; 13(3): 9-13. Available from:
http://escholarship.org/uc/item/2m43548
5. Urioste SS, Arndt KA, Dover JS. Keloid and hypertrophic scars: Review and
treatment strategies. Seminars in Cutaneous Medicine and Surgery [internet]
1999; 18(2): 159-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/
10385284
6. Robles DT, Berg D. Abnormal wound healing: keloids. Clinics in Dermatology
[internet] 2007; 25: 26-32. DOI:10.1016/j.clindermatol.2006.09.009
7. Putra IB, Jusuf NK. Studi Retrospektif Keloid di Poliklinik Kulit dan Kelamin
RSUP H. Adam Malik Medan. 12th Asia-Pasific Environmental and Occupational
Dermatology Symposium; 2013 Oct 23-26; Yogyakarta: Indonesia
8. Juckett G, Adams HH. Management of keloids and hypertrophic scars. Am Fam
Physician
2009;
80(3):
253-260.
Available
from:
http://www.aafp.org/afp/20090801/253-s1.html.
9. Kranendonk S, Obagi S. An algorithmic approach to hypertrophic scars and
keloids: Maximizing nonsurgical options. Cosmetic Dermatology [internet]
2011; 24(1). Available from: http://www.cosderm.com/fileadmin/qhi_archive/
ArticlePDF/CD/024010028.pdf
10. Wolfram D, Tzankov A, Pulzi P. Hypertrophic scars and keloids – A review of
their pathophysiology, risk factors, and therapeutic management. Dermatol Surg
2009; 35: 171-81. DOI: 10.1111/j.1524-4725.2008.34406.x
11. Prabhu A, Sreekar H, Powar R, Uppin VM. A randomized controlled trial
comparing the efficacy of intralesional 5-fluorouracil versus triamcinolone
acetonide in the treatment of keloid. Journal of the scientific society 2012; 39(1):
19-25. DOI: 10.4103/0974-5009.96466
74
75
12. Darougheh A, Asilian A, Shariati F. Intralesional triamcinolone alone or in
combination with 5-flurouracil for the treatment of keloid and hypertrophic scars.
Clinical and Experimental Dermatology 2007; 34: 219-23. DOI:10.1111/j.13652230.2007.02631.x
13. Hatamipur E, Mehrabi S, Hatamipoor M. Effects of combined intralesional 5flurouracil and topical silicone in prevention of keloid: A double blind
randomized clinical trial study. Acta Medica Iranica [internet] 2011; 49(3): 12730. Available from: http://acta.tums.ac.ir/files/journals/1/articles/4307/public/
4307-4664-1-PB.pdf
14. Perdanakusuma D. Parut abnormal. Dalam : Perdanakusuma D, Noer MS, editor.
Penanganan parut hipertropik dan keloid. Airlangga University Press. 2006 : 1326
15. Gautglitz GG, Korting HC, Pavicic T, et al. Hypertropic scarring and keloids :
Pathomechanisms and current and emerging treatment strategies. Mol Med 2011;
17(1) : 113 – 25. DOI: 10.2119/molmed.2009.00153
16. Butler PD, Longaker MT, Yang GP. Current progress in Keloid Research and
Treatment.
J. Am Coll of Surg 2008; 206(4), 731 – 40.
DOI:10.1016/j.jamcollsurg.2007.12.001
17. Alaish SM, Yager DR. Hyaluronic acid metabolism in keloid fibroblast. Journal
of Pediatric Surgery [internet] 1995; 30(7): 949-52. Available from:
http://www.jpedsurg.org/article/0022-3468%2895%2990319-4/pdf
18. Lee SS, Yosipovitch G, Chan YH, et al. Pruritus, pain, and small nerve fiber
function in keloids: a controlled study. J Am Acad Dermatol. 2004;51:1002-6.
DOI:10.1016/j.jaad.2004.07.054
19. Miteva M, Romanelli P. Hypertrophic and keloidal scars. In: Tosti A, Padova
MP, Beer KR, editors. Acne scars classification and treatment. Informa
Healthcare: 11-7
20. Hochman B, Localli RF. Intralesional triamcinolone acetonide for keloid
treatment: A systemic review . Aesth plast Surg 2008; 32: 705-9. DOI
10.1007/s00266-008-9152-8
21. Ogawa R. The most current algorithms for the treatment and prevention of
hypertrophic scars and keloids. Plast Reconstr Surg [internet] 2012; 125: 557-567.
DOI: 10.1097/PRS.0b013e3181c82dd5
22. Cho SB, Lee JH, Lee SH. Efficacy and safety of 1064 nm Qswitch Nd:YAG laser
with low fluence for keloids and hypertrophic scars. Journal European Academy
of Dermatology and Venerreology. 2010;24 : 1070-4. DOI: 10.1111/j.14683083.2010.03593.x
23. Shridharani MS, Magarakis M. Emerging role of antineoplastic agents in the
treatment of keloids and hypertrophic scars. Annals of Plast Surg 2010: 64: 35561. DOI: 10.1097/SAP.0b013e3181afaab0.
76
24. Gauglitz GG. Management of keloids and hypertrophic scars: current and
emerging options. Clinical, Cosmetic and Investigational Dermatology [internet]
2013; 6 : 103–14. Available from: http://dx.doi.org/10.2147/CCID.S35252
25. Berman B, Villa AM, Ramirez CC. Novel opportunities in the treatment and
prevention of scarring. J Cutan Med Sur [internet] 2005: 32-6. Available from:
http://link.springer.com/content/pdf/10.1007/s10227-004-0806-0.pdf
26. Qiao WX, Kai LY, Chun Q, et al. A Review of the Effectiveness of Antimitotic
Drug Injections for Hypertrophic Scars and Keloids. Ann Plast Surg 2009; 63:
688–92. DOI: 10.1097/SAP.0b013e3181978753
27. Putra IB. Pengaruh ekstrak kelopak bunga rosella (Hibiscus sabdariffa l) terhadap
penghambatan proliferasi sel fibroblast keloid manusia. Disertasi. Medan :
Program Doktor S3 Ilmu Kedokteran Fakultas Kedokteran Universitas Sumatra
Utara; 2012
28. Kelly AP. Update on the management of keloids. Semin Cutan Med Surg 2009;
28 : 71-6. DOI:10.1016/j.sder.2009.04.002
29. Nanda S, Reddy BS. Intralesional 5-Fluorouracil as a treatment modality of
keloids. Dermatol Surg [internet]
2004; 30(1): 54-6. Available from:
http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4725.2004.29382.x/pdf
30. Qiao WX, Kai LY, Yong WZ. Antimitotic drug injections and radiotherapy : A
review of the effectiveness of the treatment for hypertrophic scars and keloid.
International Journal of Lower Extremity Wound 2008; 7(3): 151-9. DOI:
10.1177/1534734608322099
31. Haurani MJ, Foreman K, Yang JJ. 5-flourouracil treatment of problematic scars.
Plastic Reconstr Surg 2009; 123: 139-47. DOI: 10.1097/PRS.0b013e3181904d1b
32. Sadeghinia A, Sadeghinia S. Comparison of the efficacy of intralesional
triamcinolon and 5-flurouracil tattooing for the treatment of keloids. Dermatol
Surg 2012; 38: 104-9. DOI: 10.1111/j.1524-4725.2011.02137.x
33. Sharma S, Bassi R, Gupta A. Treatment of small keloids with intralesional 5fluorouracil alone vs intralesional triamcinolone with 5-fluorouracil. Journal of
Pakistan Association of Dermatologist [internet] 2012; 22: 35-40. Available
from: http://www.jpad.org.pk/January-March2012/7.Original_article_Treatment_
keloids_5-FU_vs_5-FU_plus_triamcinolone_proofread.pdf
34. Gupta S, Kalra A. Efficacy and safety of intralesional 5-Fluorouracil in the
treatment of keloids. Dermatology [internet] 2002; 204(2): 130-32. Available
from: http://karger.com/journals/drm
35. Huang L, Wong YP, Cai YJ, et al. Low dose 5-fluorouracil induces cell cycle G2
arrest and apoptosis in keloid fibroblasts. British Association of Dermatologists
2010 ;163 : 1181–5. DOI 10.1111/j.1365-2133.2010.09939.x
77
36. Kontochristopoulus G, Stefanaki C, Panagiotopoulos A, et all. Intralesional 5Fluorouracil in the treatment of keloids: an open clinical trial and histopathologic
study. J Am Acad Dermatol. 2005; 52(3): 474-9. DOI:10.1016/j.jaad.2004.09.018
37. Pratchyapruit W, Vashrangsi N. A new therapeutic modality intralesional 5flourouracil in the treatment of keloids and hypertrophic scar. Institute of
Dermatology 2010; (10)2: 157-63. DOI 10.1007/s00266-006-0253-y
38. Werth VP. Systemic glucocorticoids. In: Wolff K, Goldsmith LA, Katz SI,
Gilrechrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in
general medicine. 7th edition. New York: Mc Graw-Hill.2008.p.2147-52
39. Bayat A, Arscott G, Ollier WER, Grouther DA, Ferguson MWJ. Keloid disease:
clinical relevance of single versus multiple site scars. The British Association of
Plastic Surgeons 2005; 58: 28-37. DOI:10.1016/j.bjps.2004.04.024
40. Naeni FF, Najafian J, Ahmadpour K. Bleomycin tattooing as a promising
therapeutic modality in large keloids and hypertrophic scars. Dermatol Surg
[internet] 2006; 32: 1023-30. Available from: http://onlinelibrary.wiley.com/
doi/10.1111/j.1524-4725.2006.32225.x/pdf.
41. Perdanasari AT, Lazzeri D, Su W, Xi W, Zheng Z, Ke Li, et al. Recent
developments in the use of intralesional injections keloid treatment. Arch Plast
Surg
[internet]
2014;
41:
620-9.
Available
from:
http://dx.doi.org/10.5999/aps.2014.41.6.620
42. Kelly AP. Medical and surgical therapies for keloids. Dermatologic Therapy.
2004,17: 212–8. DOI:10.1016/J.Sder.2009.04.002
43. Saha. AK. A comparative clinical study on role of 5-flurouracil versus
triamcinolone in the treatment of keloids. Indian J Surg. 2012: 1-4. DOI
10.1007/s12262-011-0399-y